chr19-29530138-G-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001146339.2(VSTM2B):c.617G>T(p.Ser206Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,461,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001146339.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152058Hom.: 0 Cov.: 34 show subpopulations
GnomAD2 exomes AF: 0.0000140 AC: 1AN: 71256 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.000116 AC: 152AN: 1309132Hom.: 0 Cov.: 32 AF XY: 0.000110 AC XY: 71AN XY: 644998 show subpopulations
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152058Hom.: 0 Cov.: 34 AF XY: 0.0000404 AC XY: 3AN XY: 74284 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.617G>T (p.S206I) alteration is located in exon 4 (coding exon 4) of the VSTM2B gene. This alteration results from a G to T substitution at nucleotide position 617, causing the serine (S) at amino acid position 206 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at